ARCHIVES

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

This article is from The Cancer Letter archive.

Vol. 24 No. 30 | July 31, 1998

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Benacerraf Named Farber President

February 8, 1980

Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR

May 4, 1979

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

In Brief: Gori to Return As Head Of Smoking Program; Wisconsin, AACI To Honor Harold Rusch

May 18, 1979